Skip to content

User-friendly HIV Testing and Counseling Services

Cohort of Individuals at Risk of HIV Infection Recruited in User-friendly HIV Testing and Counseling Services in Thailand Provinces

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04585165
Enrollment
3000
Registered
2020-10-14
Start date
2020-10-19
Completion date
2024-12-31
Last updated
2023-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B, Chronic, Hepatitis C, HIV Infections, Sexually Transmitted Infection

Keywords

HIV, Testing, Self-testing, Retesting, Early diagnosis, Counseling, Computer, Reminder, Short message service, Pre-exposure prophylaxis

Brief summary

Multicenter cohort study of individuals reporting behavioral risks of HIV acquisition, recruited among those presenting for testing for HIV and other sexually transmitted infections. Overarching goal: to study factors associated with uptake of HIV prevention and (re)testing services in medium-sized cities in Thailand. Primary objective: To estimate the incidence of HIV and other sexually transmitted infections (syphilis, chronic hepatitis B and C) among individuals presenting for retesting. Secondary objectives: * To evaluate the uptake of pre-exposure prophylaxis * To assess retention in the study * To evaluate client HIV knowledge * To describe HIV prevalence and characteristics of individuals newly diagnosed with HIV * To describe characteristics of individuals at risk of HIV infection * To assess the quality of the testing and referral services.

Detailed description

Testing and counseling for HIV, syphilis and other sexually transmitted infections is provided to consenting individuals. Components: interactive counseling program, self sampling (finger prick) under supervision, questionnaire (on a tablet computer) to assess risks of HIV acquisition, understanding of HIV transmission routes and pre-exposure prophylaxis, willingness to take pre-exposure prophylaxis if at risk of HIV, and satisfaction with regard to services provided. Referral to appropriate care facility of participants diagnosed with infection. HIV negative participants with significant risk of HIV are advised to come back for HIV retesting within 3 to 6 months and informed about pre-exposure prophylaxis.

Interventions

None listed

Sponsors

Expertise France-L'Initiative
CollaboratorUNKNOWN
French National Research Institute for Sustainable Development (IRD)
CollaboratorUNKNOWN
Institut de Recherche pour le Developpement
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Aged 15 years or more * Willing to be tested for HIV and other sexually transmitted infections * Able to understand the study and its procedures

Exclusion criteria

None

Design outcomes

Primary

MeasureTime frameDescription
HIV incidenceThrough study completion, an average of 3 yearsHIV incidence

Secondary

MeasureTime frameDescription
Participants initiating pre-exposure prophylaxisThrough study completion, an average of 3 yearsProportion of participants initiating pre-exposure prophylaxis among those at significant risk of HIV
RetentionThrough study completion, an average of 3 yearsCumulative probability of retest
HIV knowledgeThrough study completion, an average of 3 yearsAnswers to a self-constructed questionnaire assessing participants' knowledge of HIV transmission routes and pre-exposure prophylaxis, following counseling. The questionnaire is composed of one multiple-choice question on HIV transmission routes and three True/False questions on pre-exposure prophylaxis. The results will be reported item by item. Exploratory data analyses may be conducted using, for example, principal component analysis.

Countries

Thailand

Contacts

Primary ContactGonzague Jourdain, MD, PhD
Gonzague.Jourdain@phpt.org+66 5324 0910
Backup ContactNicolas Salvadori, PhD
Nicolas.Salvadori@phpt.org+66 5324 0910

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026